Several different PON-1 polymorphisms have been identified in the Japanese population and have been linked to a differential risk for atherogenic dyslipidemia, diabetes, diabetic microvascular complications, stroke, and osteoporosis [63,64,65,66,67,68,69]. The gene discussed is PON1; the disease is metabolic syndrome.